Back
ESC Premium Access

Prevalence and predictors of inappropriate DOAC prescription on first attendance at a dedicated atrial fibrillation clinic

Session: Atrial fibrillation e-posters
Topic: Oral Anticoagulation
Speaker: Doctor S. Suleiman (Dublin, IE)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Suleiman Suleiman

Tallaght University Hospital, Dublin (Ireland)
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Nishinomiya, JP)

Access
Abstract
Slides
Thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Access
Abstract
Slides
Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Access
Abstract
Slides
Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Access
Abstract
Slides
Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Doctor S. Suleiman, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...
Access
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: how to implement the guidelines and take-home message.

27 August 2021

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: what do the guidelines say?

27 August 2021

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: case presentation.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk